Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-01-26 @ 9:31 PM
Study NCT ID:
NCT00790218
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2008-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Can-Fite BioPharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CF102-102HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None